Na Zhao
- Molecular Biology top 5%
- Cancer Research top 5%
- Cell Biology top 5%
- Oncology top 10%
- Epidemiology top 10%
- Co-authors
- Shi‐Mei ZhuangYifei LvRuizhi WangFeifei YangGuohong XieQingxiang ZhouYing ZhuJian‐Hong Fang
- Topics
- MicroRNA in disease regulation (13 papers)Histone Deacetylase Inhibitors Research (12 papers)Protein Degradation and Inhibitors (10 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Na Zhao
104 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 133
- Molecular Biology 1.3k
- Cancer Research 588
- Cell Biology 284
- Oncology 271
- Epidemiology 260
Countries citing papers authored by Na Zhao
This map shows the geographic impact of Na Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Zhao more than expected).
Fields of papers citing papers by Na Zhao
This network shows the impact of papers produced by Na Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Zhao. The network helps show where Na Zhao may publish in the future.
Co-authorship network of co-authors of Na Zhao
This figure shows the co-authorship network connecting the top 25 collaborators of Na Zhao. A scholar is included among the top collaborators of Na Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Zhao. Na Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 31 | |
| 13 | 43 | |
| 14 | 31 | |
| 15 | 7 | |
| 16 | 17 | |
| 17 | 54 | |
| 18 | 5 | |
| 19 | 13 | |
| 20 | 61 |
About Na Zhao
Na Zhao is a scholar working on Cancer Research, Molecular Biology and Complementary and alternative medicine, having authored 119 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Histone Deacetylase Inhibitors Research (12 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Cancer Research (588 citations), Molecular Biology (1.3k citations) and Cell Biology (284 citations). Na Zhao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shi‐Mei Zhuang, Yifei Lv, Ruizhi Wang, Feifei Yang, Guohong Xie, Qingxiang Zhou, Ying Zhu, Jian‐Hong Fang, Di Ge and Yihua Chen. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.